Company: SYRA
Filing Date: 2025-03-11
Form Type: 10-K
Source: 0001493152-25-009873
Chunk: 515

Company: Syra Health Corp
Filing Date: 2025-03-11
Form: 10-K
Item: Item 3
Chunk 515
---
 of internal controls
over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act and (ii) complying with any requirement that may be adopted
by the Public Company Accounting Oversight Board (“PCAOB”) regarding mandatory audit firm rotation or a supplement to the
auditor’s report providing additional information about the audit and the financial statements, known as the auditor discussion
and analysis. We will remain an “emerging growth company” until the earliest of (i) the last day of the fiscal year in which
we have total annual gross revenues of $1.235 billion or more; (ii) the last day of our fiscal year following the fifth anniversary of
the date of the completion of this offering; (iii) the date on which we have issued more than $1 billion in nonconvertible debt during
the previous three years; or (iv) the date on which we are deemed to be a large accelerated filer under the rules of the SEC.

ITEM
7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

We
are not required to provide the information required by this Item as are a “smaller reporting company,” as defined in Rule
12b-2 of the Exchange Act.

-34-

ITEM
8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

SYRA
HEALTH CORP.

INDEX
TO FINANCIAL STATEMENTS

    Report of Independent Registered Public Accounting Firm (PCAOB Firm ID: 2738)
     
    F-2

    Balance Sheets at December 31, 2024 and 2023
     
    F-3

    Statements of Operations for the Years Ended December 31, 2024 and 2023
     
    F-4

    Statements of Stockholders’ Equity for the Years Ended December 31, 2024 and 2023
     
    F-5

    Statements of Cash Flows for the Years Ended December 31, 2024 and 2023
     
    F-6

    Notes to the Financial Statements
     
    F-7

F-1

REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To
the Board of Directors and

Stockholders
of Syra Health Corp.

Opinion
on the Financial Statements

We
have audited the accompanying balance sheets of Syra Health Corp. (the Company) as of December 31